bazedoxifene has been researched along with shikonin in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (shikonin) | Trials (shikonin) | Recent Studies (post-2010) (shikonin) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 660 | 2 | 505 |
| Protein | Taxonomy | bazedoxifene (IC50) | shikonin (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1392 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 6.6 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 6.2933 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 0.22 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.4 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 6.6 | |
| Class A sortase SrtA | Staphylococcus aureus | 2.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardine, C; Craik, CS; O'Donnell, HR; Shoichet, BK; Tummino, TA | 1 |
1 other study(ies) available for bazedoxifene and shikonin
| Article | Year |
|---|---|
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
Topics: Antiviral Agents; COVID-19 Drug Treatment; Drug Repositioning; Molecular Docking Simulation | 2021 |